
John Schieffelin
Interim Division Chief, Infectious Diseases · Tulane University School of Medicine
Credentials: · · · · ·
History
- Present
Infectious Diseases Division · Tulane University School of Medicine
- 2005–2006
- 1997–2001
Research
Clinical illness and outcomes in patients with Ebola in Sierra Leone
New England Journal of Medicine · 2014 · First of 50 authors · 404 citations
Virus genomes reveal factors that spread and sustained the Ebola epidemic
Nature · 2017 · 288 citations
Ebola Virus Epidemiology, Transmission, and Evolution during Seven Months in Sierra Leone
Cell · 2015 · 228 citations

12 papers

12 papers

10 papers
- SJ
8 papers

7 papers
- MO
7 papers

7 papers · 5 as a resident

6 papers
Grants
- 2019–2028
Partnership for Research in Emerging Viral Infections-Sierra Leone (PREVSL)
Fogarty International Center · D43
Contact PI · $895.4K · Tulane University of Louisiana
- 2023–2028
The Protective and Pathologic Features of the EVD Survivor Immune System
National Institute of Allergy and Infectious Diseases · R01
PI · $2.8M · Univ of North Carolina Chapel Hill
- 2022–2027
Genetic, Structural and Functional Profiling of the Human Antibody Response to Arenavirus Infection
National Institute of Allergy and Infectious Diseases · R01
PI · $4.4M · Scripps Research Institute, the
- 2020–2025
Tulane University COVID Antibody and Immunity Network (TUCAIN) Supplement
National Cancer Institute · U54
Project lead · $906.4K · Tulane University of Louisiana
Clinical trials
- 2025–2026
REVIVE (Response to the Ebola Virus Vaccine)
Principal investigator · Active not recruiting · Phase 4
Tulane University


